Aβ-induced modifications of CRMP2 could possibly result in impaired axonal transport and synapse loss: pathological processes associated with AD (Hensley and Kursula, 2016; Yang et al., 2017). This evidence concerns the gene DPYSL2 and Alzheimer disease.